The Office of Justice Programs Convicted Offender
DNA Sample Backlog Reduction Grant Program

Report No. 02-20
May 2002
Office of the Inspector General

TABLE OF CONTENTS

EXECUTIVE SUMMARY

INTRODUCTION

FINDINGS AND RECOMMENDATIONS

  1. Program Impact and Achievement of Performance Measurements

    Impact of the Program on the National Offender Backlog
    Impact of Program Grants on State Productivity
    Program Performance Measurements
    Recommendation

  2. Contractor Compliance with Quality Assurance Standards

    Myriad Genetic Laboratories, Inc.
    The Bode Technology Group
    ReliaGene Technologies, Inc.
    Recommendations

  3. OJP Oversight and Grantee Compliance with Program Requirements

    OJP Oversight and Grantee Reporting
    Timeliness
    Compliance with Offender Quality Assurance Standards
    No-Suspect Match Requirement
    Recommendation

STATEMENT ON COMPLIANCE WITH LAWS AND REGULATIONS

STATEMENT ON MANAGEMENT CONTROLS

APPENDIX I - OBJECTIVES, SCOPE, AND METHODOLOGY

APPENDIX II - GLOSSARY OF TERMS AND ACRONYMS

APPENDIX III - AUDIT CRITERIA

APPENDIX IV - FACTORS INFLUENCING THE BACKLOG

APPENDIX V - OJP COMMENTS ON THE AUDIT RECOMMENDATIONS

APPENDIX VI - OFFICE OF THE INSPECTOR GENERAL AUDIT DIVISION ANALYSIS AND SUMMARY OF ACTIONS NECESSARY TO CLOSE REPORT